EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma

Wenyan Jiang iD, Qiong Wei, Haiqin Xie, Dandan Wu, Haiyan He iD, Xuedong Lv iD

Analytical Cellular Pathology · 2023

DOI: 10.1155/2023/4522045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Cellular Pathology, 2023. Verfasst von Wenyan Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The Second Affiliated Hospital of Nantong University, Nantong 226001, China. Hauptthemen laut MEDLINE: Adenocarcinoma, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

PTGES3 is upregulated in multiple cancer types and promotes tumorigenesis and progression. However, the clinical outcome and immune regulation of PTGES3 in lung adenocarcinoma (LUAD) are not fully understood. This study aimed to explore the expression level and prognostic value of PTGES3 and its correlation with potential immunotherapy in LUAD.

Methods

All data were obtained from several databases, including the Cancer Genome Atlas database. Firstly, gene and protein expression of PTGES3 were analyzed using Tumor Immune Estimation Resource (TIMER), R software, Clinical Proteomic Tumor Analysis Consortium (CPTAC), and Human Protein Atlas (HPA). Thereafter, survival analysis was conducted using the R software, Gene Expression Profiling Interactive Analysis 2 (GEPIA2), and Kaplan–Meier Plotter. In addition, gene alteration and mutation analyses were conducted using the cBio Cancer Genomics Portal (cBioPortal) and Catalog of Somatic Mutations in Cancer (COSMIC) databases. The molecular mechanisms associated with PTGES3 were assessed via Search Tool for the Retrieval of Interacting Genes/Proteins (STRING), GeneMANIA, GEPIA2, and R software. Lastly, the role of PTGES3 in immune regulation in LUAD was investigated using TIMER, Tumor‐Immune System Interaction Database (TISIDB), and SangerBox.

Results

The gene and protein expression of PTGES3 were elevated in LUAD tissues and compared to the normal tissues, and the high expression of PTGES3 was correlated with cancer stage and tumor grade. Survival analysis revealed that overexpression of PTGES3 was associated with poor prognosis of LUAD patients. Moreover, gene alteration and mutation analysis revealed the occurrence of several types of PTGES3 gene alterations in LUAD. Moreover, co‐expression analysis and cross‐analysis revealed that three genes, including CACYBP, HNRNPC , and TCP1 , were correlated and interacted with PTGES3. Functional analysis of these genes revealed that PTGES3 was primarily enriched in oocyte meiosis, progesterone‐mediated oocyte maturation, and arachidonic acid metabolism pathways. Furthermore, we found that PTGES3 participated in a complex immune regulation network in LUAD.

Conclusion

The current study indicated the crucial role of PTGES3 in LUAD prognosis and immune regulation. Altogether, our results suggested that PTGES3 could serve as a promising therapeutic and prognosis biomarker for the LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaAdenocarcinoma of LungLung NeoplasmsHumansBiomarkers, TumorCalcium-Binding ProteinsCarcinogenesisProteomicsProstaglandin-E Synthases

Substanzen

Biomarkers, TumorCalcium-Binding ProteinsCACYBP protein, humanPTGES3 protein, humanProstaglandin-E Synthases

Autor:innen und Institutionen

  • Department of Respiratory Medicine, The Second Affiliated Hospital of Nantong University, Nantong 226001, China.

ORCID-Profile: Wenyan Jiang, Haiyan He, Xuedong Lv

Förderung

  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Jiang, W., Wei, Q., Xie, H., Wu, D., He, H., & Lv, X. (2023). Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma. Analytical Cellular Pathology. https://doi.org/10.1155/2023/4522045

Vancouver

Jiang W, Wei Q, Xie H, Wu D, He H, Lv X. Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma. Analytical Cellular Pathology. 2023. doi:10.1155/2023/4522045

BibTeX
@article{Jiang2023,
  author = {Jiang, Wenyan and Wei, Qiong and Xie, Haiqin and Wu, Dandan and He, Haiyan and Lv, Xuedong},
  title = {Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma},
  journal = {Analytical Cellular Pathology},
  year = {2023},
  doi = {10.1155/2023/4522045}
}
Kostenlos starten →